The Centers for Medicare & Medicaid Services today awarded $8.6 million to 30 states and the District of Columbia to provide state insurance regulators with the opportunity to enhance states’ ability to strengthen their health insurance markets through innovative measures. CMS said states can use the funds, which include individual grants ranging from $225,000 to $285,000, to conduct economic analyses and market scans of the state’s health insurance market to improve and expand the number of affordable health care coverage options under new flexibilities offered to states by CMS guidance and regulations. States also can use the funds to examine plan policies, procedures and claims-related data related to access to mental health and substance use disorder treatment services, including opioid treatment services. “We recognize that states are in the best position to assess the needs of their consumers and develop innovative measures to ensure access to affordable health coverage,” said CMS Administrator Seema Verma. The funding is part of $250 million for State Rate Review Grants provided by the Affordable Care Act to improve the process for how states review proposed health insurance rates. The funds announced today are unspent Rate Review Grant funding from prior years. Click here to see how the funding is allocated to each state.

Related News Articles

Headline
The Centers for Medicare…
Headline
The National Institutes of Health today selected several universities to partner with communities in Kentucky, Massachusetts, New York and Ohio to study the…
Headline
Precancerous cervical lesions associated with human papillomavirus declined sharply in women aged 18–24 between 2008 and 2016, likely reflecting increasing HPV…
Headline
The Federal Trade Commission will hold a public workshop June 18 in Washington, D.C., to assess the impact of certificates of public advantage on health care…
Headline
The Medicaid and CHIP Payment and Access Commission yesterday recommended that Congress change the definition of Medicaid shortfall to exclude costs and…
Headline
The House Ways and Means Committee today approved the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113), AHA-supported…